Antibiotic resistance patterns of multidrug resistant bacteria in acute myeloid leukemia patients during induction

Lazar Trajković1, Mirjana Cvetković1, Mirjana Mitrović1

  • 1Clinic of Hematology, University Clinical Centre of Serbia, Belgrade, Serbia.

Abstract

Insights

Infections are common in acute myeloid leukemia (AML) patients during induction therapy. Multi-drug resistant (MDR) and extensively drug-resistant (XDR) Klebsiella spp. and Enterococcus spp. cause high mortality rates.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Microbiology

Background:

  • Acute myeloid leukemia (AML) treatment, especially induction therapy, frequently leads to infectious complications.
  • The rise of multi-drug resistant (MDR) bacteria poses a significant challenge in managing AML patients.

Purpose of the Study:

  • To analyze the patterns and outcomes of infectious complications in AML patients undergoing induction therapy.
  • To identify the prevalence and resistance profiles of bacterial isolates, focusing on MDR and extensively drug-resistant (XDR) strains.

Main Methods:

  • A retrospective analysis of 84 AML patients hospitalized between October 2020 and April 2023.
  • Identification and antimicrobial resistance profiling of 95 bacterial isolates.

Main Results:

  • Enterococcus spp. and Klebsiella spp. were the most frequent Gram-positive and Gram-negative bacteria, respectively.
  • High resistance rates were observed for vancomycin (56%) in Enterococcus spp. and carbapenems (84.6%) in Klebsiella spp.
  • XDR Klebsiella spp. (57.7%) and MDR Enterococcus spp. (40%) were prevalent. Factors associated with MDR infections included poor performance status, sepsis, and multiple infectious syndromes. MDR bacterial infections were linked to a 36.7% mortality rate.

Conclusions:

  • Infections are frequent in AML patients, particularly those caused by MDR and XDR Klebsiella spp. and Enterococcus spp.
  • These resistant bacterial strains are associated with high early mortality rates in AML patients undergoing induction therapy.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K